Cargando…
Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
Glycogen Synthase Kinase-3β (GSK3β) is a serine/threonine kinase, known to regulate various cellular processes including proliferation, differentiation, survival, apoptosis as well as TRAIL-resistance. Thus pathways that can modulate GSK3β axis are important targets for cancer drug development. Our...
Autores principales: | Santha, Sreevidya, Davaakhuu, Gantulga, Basu, Aninda, Ke, Rong, Das, Subhasis, Rana, Ajay, Rana, Basabi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341845/ https://www.ncbi.nlm.nih.gov/pubmed/27602497 http://dx.doi.org/10.18632/oncotarget.11834 |
Ejemplares similares
-
Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
por: Ke, Rong, et al.
Publicado: (2018) -
Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells
por: Mishra, Prajna, et al.
Publicado: (2010) -
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
por: Mamaghani, Shadi, et al.
Publicado: (2012) -
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020) -
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
por: Viswakarma, Navin, et al.
Publicado: (2017)